Intestinal Microbiota Composition After Antibiotic Treatment in Early Life (INCA)
Intestinal Microbiota Composition After Antibiotic Treatment in Early Life. The INCA Study
Sponsor: Agentschap NL
This observational or N/A phase trial investigates Atopy and Eczema and is currently ongoing. Agentschap NL leads this study, which shows 13 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Jan 2025 — Present [monthly]
Unknown
-
Sep 2024 — Jan 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status
-
Dec 2021 — May 2022 [monthly]
Unknown Status
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Agentschap NL
- Amsterdam UMC, location VUmc
- Danone Global Research & Innovation Center
For direct contact, visit the study record on ClinicalTrials.gov .